http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14744619

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 6; authors reply 766
issn 1542-6270
1060-0280
issueIdentifier 5
pageRange 765-6; authors reply 766
publicationName The Annals of pharmacotherapy
startingPage 765
bibliographicCitation Trinka E, Höfler J, Tilz C, Kellinghaus C. Comment: lacosamide for the treatment of refractory status epilepticus. Ann Pharmacother. 2012 May;46(5):765–6; authors reply 766. doi: 10.1345/aph.1q461a. PMID: 22570435.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f50f1cbe668b21a7e0fa37d4a8aadf42
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5950-2692
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_864b9f16bf298043f09f5e66f06d036c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64ff962f98bd500aea50c20365497061
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2399439874d692f23c5b4ecb9cbc89e3
date 201205
identifier https://pubmed.ncbi.nlm.nih.gov/22570435
https://doi.org/10.1345/aph.1q461a
isPartOf https://portal.issn.org/resource/ISSN/1542-6270
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1999
https://portal.issn.org/resource/ISSN/1060-0280
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Comment: Lacosamide for the Treatment of Refractory Status Epilepticus
discusses http://id.nlm.nih.gov/mesh/M0000113
http://id.nlm.nih.gov/mesh/M0001382
http://id.nlm.nih.gov/mesh/M0356576
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D013226Q000188
http://id.nlm.nih.gov/mesh/D004351Q000187
http://id.nlm.nih.gov/mesh/D000081Q000627
http://id.nlm.nih.gov/mesh/D000927Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000078334
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID219078

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129508865

Total number of triples: 36.